Association of the Receptor for Advanced Glycation End Products Gene Polymorphisms with Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis
Ophthalmologica, 04/26/2012Yuan D et al.
The authors' research confirmed an association between the receptor for advanced glycation end products (RAGE) –374T/A polymorphism and retinopathy in subjects with type 2 diabetes and the –374AA allele was found to be a protective factor for type 2 diabetes. Otherwise, the RAGE Gly82Ser polymorphism might be considered a significant risk for diabetic retinopathy in Asian populations.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.